Effect of platelet activation on the agglutination of platelets by von Willebrand factor
Agglutination of human platelets by bovine von Willebrand factor (vWF) or by human vWF in the presence of ristocetin is inhibited by ADP and by several other platelet agonists but not by epinephrine. Vincristine, which causes a shape change by disrupting microtubules, neither inhibited agglutination...
Saved in:
Published in | Molecular pharmacology Vol. 37; no. 2; pp. 271 - 277 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Pharmacology and Experimental Therapeutics
01.02.1990
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Agglutination of human platelets by bovine von Willebrand factor (vWF) or by human vWF in the presence of ristocetin is inhibited
by ADP and by several other platelet agonists but not by epinephrine. Vincristine, which causes a shape change by disrupting
microtubules, neither inhibited agglutination nor blocked the effect of ADP. The action of ADP was blocked by ATP, by p-fluorosulfonylbenzoyladenosine,
and by the thiol-reactive regents cytochalasin A and p-chloromercuribenzenesulfonate. In contrast to its effects on vWF, ADP
enhanced agglutination induced by wheat germ lectin. ADP caused a small decrease in the number and affinity of binding sites
for vWF on platelets, too small to explain the inhibition of agglutination. The ability of ADP and other agonists to inhibit
agglutination appears to be related neither to inhibition of adenylate cyclase nor to the loss of their discoid shape but
rather to the membrane changes that accompany the shape change. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0026-895X 1521-0111 |